Correspondence 0001213900-24-034646 from MESOBLAST LTD (MESO, MEOBF) (CIK 0001345099) (MESO)
MESOBLAST LTD (MESO, MEOBF) (CIK 0001345099)
Date: April 22, 2024 · CIK: 0001345099 · Accession: 0001213900-24-034646
AI Filing Summary & Sentiment
File numbers found in text: 333-278727
Letter
Mesoblast Limited
Level 38, 55 Collins Street
Melbourne, VIC 3000
Australia
April 22, 2024
via EDGAR
Securities and Exchange Commission
Division of Corporation Finance
F Street, N.E.
Washington, DC 20549
Re: Mesoblast Ltd
Registration Statement on Form F-3
Filed: April 16, 2024
Securities Act File No. 333-278727
Request for Acceleration of Effectiveness
Ladies and Gentlemen:
Pursuant to Rule 461 under the Securities Act of 1933, Mesoblast Limited (the “Registrant”) hereby respectfully requests acceleration of its Registration Statement on Form F-3 (File No. 333-278727), filed on April 16, 2024, so that it will become effective at 9:00 a.m. (Eastern time) on April 24, 2024, or as soon as practicable thereafter.
If you have any questions, or require any additional information, please do not hesitate to email Andrew Reilly, the Registrant’s outside counsel, at andrew.reilly@rimonlaw.com.
The Registrant hereby acknowledges that, if the Securities and Exchange Commission (or its staff, acting pursuant to delegated authority) (the “Commission”) declares the filing effective, such action:
(i) does not foreclose the Commission from taking any action with respect to the filing;
(ii) does not relieve the Registrant from its full responsibility for the adequacy and accuracy of the disclosure in the filing; and
(iii) may not be asserted by the Registrant as a defence in any proceeding initiated by the Commission or any person under the federal securities laws of the United States.
Very truly yours,
Mesoblast Limited
Show Raw Text
CORRESP
1
filename1.htm
Mesoblast
Limited
Level
38, 55 Collins Street
Melbourne,
VIC 3000
Australia
April
22, 2024
via
EDGAR
Securities
and Exchange Commission
Division
of Corporation Finance
100
F Street, N.E.
Washington,
DC 20549
Re:
Mesoblast
Ltd
Registration
Statement on Form F-3
Filed:
April 16, 2024
Securities
Act File No. 333-278727
Request
for Acceleration of Effectiveness
Ladies
and Gentlemen:
Pursuant
to Rule 461 under the Securities Act of 1933, Mesoblast Limited (the “Registrant”) hereby respectfully requests acceleration
of its Registration Statement on Form F-3 (File No. 333-278727), filed on April 16, 2024, so that it will
become effective at 9:00 a.m. (Eastern time) on April 24, 2024, or as soon as practicable thereafter.
If
you have any questions, or require any additional information, please do not hesitate to email Andrew Reilly, the Registrant’s
outside counsel, at andrew.reilly@rimonlaw.com.
The
Registrant hereby acknowledges that, if the Securities and Exchange Commission (or its staff, acting pursuant to delegated authority)
(the “Commission”) declares the filing effective, such action:
(i) does
not foreclose the Commission from taking any action with respect to the filing;
(ii) does
not relieve the Registrant from its full responsibility for the adequacy and accuracy of the disclosure in the filing; and
(iii) may
not be asserted by the Registrant as a defence in any proceeding initiated by the Commission or any person under the federal securities
laws of the United States.
Very truly yours,
Mesoblast Limited
By:
/s/
Andrew Chaponnel
Andrew Chaponnel
Interim Chief Financial
Officer